1570077-24-5

Basic information

• Product Name: 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide
• Synonyms: 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide
• CAS NO: 1570077-24-5
• Molecular Weight: 544.598
• Mol File: 1570077-24-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide(1570077-24-5)
• EPA Substance Registry System: 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide(1570077-24-5)

Safety Data

• Hazardous Substances Data: 1570077-24-5(Hazardous Substances Data)

Upstream product

• 1570084-80-8 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(N-cyano-S-(methyl)sulfinimidoyl)benzylamide 
• 1570084-78-4 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 3-methyl-4-(methylsulfanyl)benzylamide 
• 1178916-64-7 3-methyl-4-(methylsulfanyl)benzylamine 
• 185147-08-4 4-fluoro-3-methylbenzonitrile 
• 918967-41-6 3-methyl-4-(methylsulfanyl)benzonitrile 

Relevant articles and documents

SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

This invention relates to substituted 4-pyridones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection, and oncological diseases.